Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268

Brain, Behavior, and Immunity

Volumn 23, Issue 6, 2009, Pages 844-850

  Giuliani, Daniela ^a   Ottani, Alessandra ^a   Minutoli, Letteria ^b   Stefano, Vincenzo Di ^b   Galantucci, Maria ^a   Bitto, Alessandra ^a,b   Zaffe, Davide ^a   Altavilla, Domenica ^b   Botticelli, Annibale R ^c   Squadrito, Francesco ^b   Guarini, Salvatore ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Functional recovery; Hippocampal damage; Ischemic stroke; Melanocortins; Zif268

Indexed keywords

ALPHA INTERMEDIN DERIVATIVE; HORMONE RECEPTOR BLOCKING AGENT; HS 024; IMMEDIATE EARLY PROTEIN; PROTEIN ZIF268; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FUNCTIONAL STATUS; GENE OVEREXPRESSION; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING; MALE; MAZE TEST; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL MEMORY; THERAPY DELAY;

ALPHA-MSH; ANIMALS; BLOTTING, WESTERN; EARLY GROWTH RESPONSE PROTEIN 1; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; LEARNING; MALE; MAZE LEARNING; MELANOCORTINS; MEMORY; RECOVERY OF FUNCTION; STROKE;

EID: 67649836294     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.03.009     Document Type: Article

References (36)

1. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., and Marsh III E.E. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24 (1993) 35-41
2. Adams H.P., Del Zoppo G., Alberts M.J., Bhatt D.L., Brass L., Furlan A., Grubb R.L., Higashida R.T., Jauch E.C., Kidwell C., Lyden P.D., Morgenstern L.B., Qureshi A.I., Rosenwasser R.H., Scott P.A., and Wijdicks E.F. Guidelines for the early management of adults with ischemic stroke. Stroke 38 (2007) 1655-1711
3. Beckmann A.M., and Wilce P.A. Egr transcription factors in the nervous system. Neurochem. Int. 31 (1997) 447-510
4. Catania A. Neuroprotective action of melanocortins: a therapeutic opportunity. Trends Neurosci. 31 (2008) 353-360
5. Cole A.J., Saffen D.W., Baraban J.M., and Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340 (1989) 474-476
6. Fisher C.M. Lacunar strokes and infarcts: a review. Neurology 32 (1982) 871-876
7. Getting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther. 111 (2006) 1-15
8. Giuliani D., Leone S., Mioni C., Bazzani C., Zaffe D., Botticelli A.R., Altavilla D., Galantucci M., Minutoli L., Bitto A., Squadrito F., and Guarini S. Broad therapeutic treatment window of the [Nle4, d-Phe7]-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur. J. Pharmacol. 538 (2006) 48-56
9. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., Bitto A., Cainazzo M., Marini H., Zaffe D., Botticelli A.R., Pizzala R., Savio M., Necchi D., Schiöth H.B., Bertolini A., Squadrito F., and Guarini S. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147 (2006) 126-1135
10. Giuliani D., Ottani A., Mioni C., Bazzani C., Galantucci M., Minutoli L., Bitto A., Zaffe D., Botticelli A.R., Squadrito F., and Guarini S. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur. J. Pharmacol. 570 (2007) 57-65
11. Gladstone D.J., Black S.E., and Hakim A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 (2002) 2123-2136
12. Guarini S., Bazzani C., and Bertolini A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br. J. Pharmacol. 121 (1997) 1454-1460
13. Guarini S., Cainazzo M.M., Giuliani D., Mioni C., Altavilla D., Marini H., Bigiani A., Ghiaroni V., Passaniti M., Leone S., Bazzani C., Caputi A.P., Squadrito F., and Bertolini A. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc. Res. 63 (2004) 357-365
14. Guarini S., Tagliavini S., Bazzani C., Ferrari W., and Bertolini A. Early treatment with ACTH-(1-24) in a rat model of hemorrhagic shock prolongs survival and extends the time-limit for blood reinfusion to be effective. Crit. Care Med. 18 (1990) 862-865
15. Guzowski J.F., Setlow B., Wagner E.K., and McGaugh J.L. Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and Zif268. J. Neurosci. 21 (2001) 5089-5098
16. Huang Q., and Tatro J.B. α-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci. Lett. 334 (2002) 186-190
17. Huh S.K., Lipton J.M., and Batjer H.H. The protective effects of α-melanocyte stimulating hormone on canine brain ischemia. Neurosurgery 40 (1997) 132-140
18. Jessberger S., and Kempermann G. Adult-born hippocampal neurons mature into activity-dependent responsiveness. Eur. J. Neurosci. 18 (2003) 2707-2712
19. Jones M.W., Errington M.L., French P.J., Fine A., Bliss T.V., Garel S., Charnay P., Bozon B., Laroche S., and Davis S. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci. 4 (2001) 289-296
20. Jonsson L., Skarphedinsson J.O., Skuladottir G.V., Watanobe H., and Schiöth H.B. Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J. Endocrinol. 173 (2002) 517-523
21. Kauselmann G., Weiler M., Wulff P., Jessberger S., Konietzko U., Scafidi J., Staubli U., Bereiter-Hahn J., Strebhardt K., and Kuhl D. The polo-like protein kinases Fnk and Snk associate with a Ca (2+)-and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J. 18 (1999) 5528-5539
22. Kee N., Teixeira C.M., Wang A.H., and Frankland P.W. Preferential incorporation of adult-generated granule cells into spatial memory network in the dentate gyrus. Nat. Neurosci. 10 (2007) 355-362
23. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239 (1982) 57-69
24. Leker R.R., and Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Rev. 39 (2002) 55-73
25. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Ståhlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., and Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28 (2008) 468-481
26. Macleod M.R., van der Worp H.B., Sena E.S., Howells D.W., Dirnagl U., and Donnan G.A. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39 (2008) 2824-2829
27. Milner B., Squire L.R., and Kandel E.R. Cognitive neuroscience and the study of memory. Neuron 20 (1998) 445-468
28. Mioni C., Bazzani C., Giuliani D., Altavilla D., Leone S., Ferrari A., Minutoli L., Bitto A., Marini H., Zaffe D., Botticelli A.R., Iannone A., Tomasi A., Bigiani A., Bertolini A., Squadrito F., and Guarini S. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit. Care Med. 33 (2005) 2621-2628
29. Morris R.G.M. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
30. Noera G., Lamarra M., Guarini S., and Bertolini A. Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24). Lancet 358 (2001) 469-470
31. Ottani A., Giuliani D., Mioni C., Galantucci M., Minutoli L., Bitto A., Altavilla D., Zaffe D., Botticelli A.R., Squadrito F., and Guarini S. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J. Cereb. Blood Flow Metab. 29 (2009) 512-523
32. Rogalewski A., Schneider A., Ringelstein E.B., and Schäbitz W.R. Toward a multimodal neuroprotective treatment of stroke. Stroke 37 (2006) 1129-1136
33. Starowicz K., and Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 73 (2003) 823-847
34. Tashiro A., Makino H., and Gage F.H. Experience-specific functional modification of the dentate gyrus through adult neurogenesis: a critical period during an immature stage. J. Neurosci. 27 (2007) 3252-3259
35. Tatro J.B. Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology 147 (2006) 1122-1125
36. Vergoni A.V., and Bertolini A. Role of melanocortins in the central control of feeding. Eur. J. Pharmacol. 405 (2000) 25-32